This session provides a review of novel therapies in urology including muscle derived cells for incontinence and nerve re-routing for neurogenic bladder. New therapies and technology currently being developed or coming to market soon are presented which will assist in providing comprehensive treatment options to patients.
Contact hours available until 3/16/2016.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Faculty, Planners and Authors Conflict of Interest Disclosure: Kenneth M. Peters, MD Grant/Research/Support: Medtronic, Uroplasty Consultant/Presenter Bureau: Medtronic, Uroplasty
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.
Describe new treatments for incontnence.
Recognize the role of neuroregeneration in the treatment of neurogenic bladder.
Outline new advances in the treatment of erectile dysfunction.